EMEA PoC Diagnostics Market Demand, Status, Analysis And Forecasts To 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report Europe, Middle East, and Africa (EMEA) Point-of-Care (PoC) Diagnostics Market Analysis By Product (Blood Gas/Electrolytes, Infectious Diseases, Hospital Glucose Testing, Cardiac Markers, Hematology, Coagulation, Primary Care Systems, Decentralized Clinical Chemistry, Urinalysis, Drug Abuse Testing, Fertility, OTC, and Rapid Diagnostic Tests) And Segment Forecasts To 2022

The EMEA PoC Diagnostics Market is expected to reach USD 7.39 billion by 2022, according to a new report by Grand View Research Inc. Incorporation of healthcare IT and telecommunication such as HealthVault concept by Microsoft plays an inevitable role in the development of the Point-of-Care (PoC) diagnostics market. The introduction of healthcare information systems such as Electronic Medical Records (EMR) has highly increased the market penetration rates of these diagnostic tests.
Rising demand for home healthcare coupled with patient awareness levels and government initiatives aimed at reducing hospital stays and healthcare expenditure are anticipated to drive the Europe, Middle East, and Africa (EMEA) PoC diagnostics market growth. On account of growing demand for self-testing, companies have launched portable devices that are easy to use such as Pandora CDx point-of-care system by POC Medical Systems.

Growing base of the geriatric population will widen the target consumer base. Aging heightens the risk of chronic diseases including cardiovascular, diabetes, and cancer. Growing base of geriatric population is anticipated to further increase the demand for continuous monitoring via facilities requiring point-of-care diagnostic products such as home healthcare and assisted living facilities.

Access Research Report of EMEA PoC Diagnostics Market @ www.grandviewresearch.com/industry-analysis/emea-point-of-care-poc-diagnostics-market

Further key findings from the study suggest:

• In 2014, glucose testing dominated the EMEA PoC market with a share of over 60%. Growing prevalence of diabetes and the introduction of portable glucose monitoring devices such as OneTouch, Accu-Chek, and Glucotouch are the major drivers for market growth over the forecast period.
• The infectious disease testing segment is expected to be the fastest-growing product, growing at a CAGR of over8.0% over the next six years. Rising prevalence of infectious disease in low- and middle-income level countries of MEA and Europe is the major aspect accounting for its fastest growth.
• Clinics are likely to account for over 37% of the market by 2022. High procedure volumes associated with clinical establishments is one of the primary reasons attributing to its huge share.
• The home healthcare segment, on the other hand, is expected to grow at a lucrative rate during the forecast period owing to its cost-effectiveness and comfort level it provides to the patients
• Germany held over 19%of the European PoC diagnostics market in 2014.Major factors attributing to growth include the presence of favorable regulations and initiatives undertaken by the government pertaining to the development of healthcare infrastructure and the integration of telecommunications and IT into point-of-care products such as MyGlucoHealth applications.
• South Africa is expected to be the fastest growing segment over the forecast period. High prevalence of malaria and other febrile infectious diseases coupled with huge population base in South Africa are the major factors driving growth of PoC market in this region
• Key market players include Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux S.A., and Alere Inc. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global EMEA PoC diagnostics market on the basis of product, end-use and region:
EMEA Point-of-Care Diagnostics Product Outlook (Revenue, USD Million, 2015 - 2022)

• Glucose testing
  • Over The Counter (OTC)
  • Prescribed
  • Cardiac markers
  • Fertility
  • Blood gas and electrolytes
  • Decentralized clinical chemistry
  • Infectious disease testing
  • CoagulationPrimary care systems
    • Over The Counter (OTC)
    • Prescribed
  • Hematology
  • Urinalysis
  • Drug abuse testing
  • Others

EMEA Point-of-Care Diagnostics End-Use Outlook (Revenue, USD Million, 2015 - 2022)

• Hospitals
• Clinics
• Laboratories
• Assisted living healthcare facilities
• Others

EMEA Point-of-Care Diagnostics Regional Outlook (Revenue, USD Million, 2015 - 2022)

• Europe
• MEA

Access Press Release of EMEA PoC Diagnostics Market @ www.grandviewresearch.com/press-release/emea-poc-diagnostics-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com